Cambridge Investment Research Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,031	Closed	-$263K	–	3060
2022 Q1	$263K	Buy	31,031 +5,713	+23%	+$40.1K	﹤0.01%	2654
2021 Q4	$224K	Buy	+25,318	New	+$241K	﹤0.01%	2775
2021 Q3	–	Sell	-167,079	Closed	-$1.75M	–	3103
2021 Q2	$1.75M	Sell	167,079 -10,534	-6%	-$104K	0.01%	1189
2021 Q1	$1.83M	Buy	177,613 +138,935	+359%	+$1.93M	0.01%	1057
2020 Q4	$429K	Buy	+38,678	New	+$395K	﹤0.01%	1876

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HVCM

HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors's SRTA Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2022, closing a stake of 31,031 shares — an estimated $263K sold.

Cambridge Investment Research Advisors first reported a position in SRTA in Q4 2020 and held it in 5 quarters. The position peaked at $1.83M in Q1 2021. 96 funds tracked by Wall St. Rank hold SRTA as of Q2 2022.

Cambridge Investment Research Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 31,031 Strata Critical Medical Inc shares in Q2 2022, an estimated $263K.
Cambridge Investment Research Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 5 quarters.
Cambridge Investment Research Advisors's Strata Critical Medical Inc position peaked at $1.83M in Q1 2021.
96 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.